Cross Country Healthcare Inc CCRN.OQ CCRN.O is expected to show a fall in quarterly revenue when it reports results on March 4 for the period ending December 31 2025
The Boca Raton Florida-based company is expected to report a 18.0% decrease in revenue to $254.29 million from $309.94 million a year ago, according to the mean estimate from 8 analysts, based on LSEG data.
LSEG's mean analyst estimate for Cross Country Healthcare Inc is for earnings of 3 cents per share.
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 8 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Cross Country Healthcare Inc is $10.50, about 20.7% above its last closing price of $8.70
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Sep. 30 2025 | 0.04 | 0.04 | 0.03 | Missed | -18.2 |
Jun. 30 2025 | 0.05 | 0.05 | -0.01 | Missed | -118.8 |
Mar. 31 2025 | 0.04 | 0.06 | 0.06 | Met | 7.7 |
Dec. 31 2024 | 0.11 | 0.12 | 0.04 | Missed | -65.4 |
Sep. 30 2024 | 0.10 | 0.10 | 0.12 | Beat | 24.7 |
Jun. 30 2024 | 0.14 | 0.13 | 0.10 | Missed | -24.5 |
Mar. 31 2024 | 0.17 | 0.17 | 0.19 | Beat | 10.9 |
Dec. 31 2023 | 0.27 | 0.27 | 0.29 | Beat | 6.1 |
This summary was machine generated March 2 at 21:10 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments